IXICO

London, United Kingdom Founded: 2004 • Age: 22 yrs
AI-based medical image management and analysis solutions for healthcare organizations
Request Access

About IXICO

IXICO is a company based in London (United Kingdom) founded in 2004.. IXICO has completed 1 acquisition, including Optimal Medicine. IXICO offers products and services including IXICO Platform, Imaging Biomarkers, and Trial Management. IXICO operates in a competitive market with competitors including Perspectum, Qure.ai, Zebra Medical Vision, Deeptek and Subtle Medical, among others.

  • Headquarter London, United Kingdom
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Ixico Plc
Operational Areas
Healthcare → Health Technology & Digital Health
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
    $7.23 M (USD)
    -13.49
    as on Sep 30, 2024
  • Net Profit
    $-2.51 M (USD)
    -69.86
    as on Sep 30, 2024
  • EBITDA
    $-3.02 M (USD)
    -117.72
    as on Sep 30, 2024
  • Latest Funding Round
    $5.2 M (USD), Post-IPO

    Nov 06, 2024

  • Investors
    Gov.uk

    & 2 more

  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of IXICO

IXICO is a publicly listed company on the LSE with ticker symbol IXI in UK, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: LSE · Ticker: IXI . Sector: Commercial services · UK

Products & Services of IXICO

IXICO offers a comprehensive portfolio of products and services, including IXICO Platform, Imaging Biomarkers, and Trial Management. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

AI-driven tool for neuroimaging and clinical trial data analysis

Provides radiological reads and MRI analysis for disease tracking

Manages global clinical trials data for neurological research

People of IXICO
Headcount 50-200
Employee Profiles 34
Board Members and Advisors 4
Employee Profiles
People
Jade Hue
Clinical Project Manager
People
Nicoletta Vitale
Senior Project Start-Up Manager
People
Serena P-Ramji
Senior Project Start-up Manager
People
Veena Supramaniam
Head Of Project Management

Unlock access to complete

Board Members and Advisors
people
Mark Warne
Non-Executive Director & Senior Independent Director
people
John Bradshaw
Non-Executive Director
people
Kate Rogers
Non-Executive Director
people
Charles Spicer
Non-Executive Chairman

Unlock access to complete

Funding Insights of IXICO

  • Total Funding
  • Total Rounds 6
  • Last Round Post-IPO — $5.2M
  • First Round

    (05 Nov 2012)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2024 Amount Post-IPO - IXICO Valuation

investors

Sep, 2016 Amount Post-IPO - IXICO Valuation

investors

Mar, 2016 Amount Grant - IXICO Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in IXICO

IXICO has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Gov.uk, Cavendish Corporate Finance and SBRI Healthcare. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Delivers business and technological solutions to identify and address healthcare challenges.
Founded Year Domain Location
Online government services and information are provided to users.
Founded Year Domain Location
Mid-market investment banking services are provided to clients.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by IXICO

IXICO has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Optimal Medicine. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
CDS platform for ADHD assessment and treatment is provided.
2012
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - IXICO

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ixico Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of IXICO

IXICO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Perspectum, Qure.ai, Zebra Medical Vision, Deeptek and Subtle Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Precision medicine software for liver disease diagnosis is offered.
domain founded_year HQ Location
AI-powered solutions for medical imaging diagnostics
domain founded_year HQ Location
Provider of AI and SaaS-based medical image based decision support tools
domain founded_year HQ Location
AI-augmented diagnostic tools for radiology imaging are developed.
domain founded_year HQ Location
AI-driven solutions for medical diagnostic imaging are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ixico

REG - IXICO plc - Share option award
London Stock Exchange1 month ago
REG - IXICO plc - Operational Update
London Stock Exchange1 month ago

Frequently Asked Questions about IXICO

When was IXICO founded?

IXICO was founded in 2004 and raised its 1st funding round 8 years after it was founded.

Where is IXICO located?

IXICO is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

What is the annual revenue of IXICO?

Annual revenue of IXICO is $7.23M as on Sep 30, 2024.

What does IXICO do?

AI-based medical image management and analysis solutions for healthcare organizations. It provides clinical trial services for drug development in the field of neurodegeneration. One of their product ASSESSSA assists in decision support to healthcare professionals. The company has two proprietary technology, TrialWire, and TrialTracker, and these are used to collect Alzheimers patients data across the world. Also, they have wearable sensors that allow the measurement of parameters, such as sleep, and activity.

Who are the top competitors of IXICO?

IXICO's top competitors include Perspectum, Qure.ai and Deeptek.

What products or services does IXICO offer?

IXICO offers IXICO Platform, Imaging Biomarkers, and Trial Management.

Is IXICO publicly traded?

Yes, IXICO is publicly traded on LSE under the ticker symbol IXI.

How many acquisitions has IXICO made?

IXICO has made 1 acquisition, including Optimal Medicine.

Who are IXICO's investors?

IXICO has 3 investors. Key investors include Gov.uk, Cavendish Corporate Finance, and SBRI Healthcare.

What is IXICO's ticker symbol?

The ticker symbol of IXICO is IXI on LSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available